330793-46-9 Usage
Uses
Used in Pharmaceutical Development:
4-(Phenethylcarbamoyl)phenylboronic acid serves as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for specific interactions with biological targets, making it a valuable component in the design of new drugs with potential therapeutic effects.
Used in Organic Synthesis:
As a boronic acid derivative, 4-(Phenethylcarbamoyl)phenylboronic acid is utilized in organic synthesis for the formation of carbon-carbon bonds, a fundamental aspect of creating complex organic molecules. Its reactivity and selectivity in various coupling reactions contribute to the synthesis of a wide range of organic compounds.
Used in Medicinal Chemistry:
4-(Phenethylcarbamoyl)phenylboronic acid is employed in medicinal chemistry for its ability to form reversible covalent bonds with biomolecules. This feature is particularly useful in the development of probes and inhibitors that can modulate biological processes at the molecular level, offering insights into disease mechanisms and potential therapeutic interventions.
Used in Chemical Biology:
In the field of chemical biology, 4-(Phenethylcarbamoyl)phenylboronic acid is used as a tool to study the interactions between small molecules and biological systems. Its specific properties allow researchers to investigate the mechanisms of action of potential drugs and to understand the molecular basis of various biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 330793-46-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,0,7,9 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 330793-46:
(8*3)+(7*3)+(6*0)+(5*7)+(4*9)+(3*3)+(2*4)+(1*6)=139
139 % 10 = 9
So 330793-46-9 is a valid CAS Registry Number.
330793-46-9Relevant academic research and scientific papers
Pyrazolopyrimidines as therapeutic agents
-
, (2008/06/13)
The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.
Pyrazolopyrimidines as therapeutic agents
-
, (2008/06/13)
The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R2, and R3 are defined as described herein.
